TrialLung2022

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.

Jaclyn A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.